| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 |
| Total Revenue |
-
|
-
|
-
|
-
|
| Cost of Revenue |
-
|
-
|
-
|
-
|
|
| Gross Profit |
-
|
-
|
-
|
-
|
|
| Operating Expenses |
| Research Development |
-
| 42 | 52 | 52 |
| Selling General and Administrative | 321 | 230 | 238 | 245 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (321) | (272) | (290) | (297) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 1 | 3 | 1 | 2 |
| Earnings Before Interest And Taxes | (320) | (269) | (289) | (295) |
| Interest Expense | 13 | 12 | 13 | 13 |
| Income Before Tax | (333) | (281) | (302) | (308) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (333) | (281) | (302) | (308) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (333) | (281) | (302) | (308) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($333) | ($281) | ($302) | ($308) |
2.20% Nasdaq 
Income Statement
